Drugs / Essentiale
last change Feb 2012 re-read 3 minutes ago

Essentiale

Developed for
fatty liver disease
Investigated by
Zhejiang University

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01148576 Jun 2010 → Dec 2011 chronic hepatitis B virus infection, fatty liver disease Zhejiang University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Essentiale ClinicalTrials.gov intervention name — accepted as the source's own label NCT01148576 ↗